Bright Minds Biosciences Inc (DRUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Operating Expenses | 2,085 | 3,535 | 3,828 | 6,954 | 2,970 |
| Operating Income | -2,085 | -3,535 | -3,828 | -6,954 | -2,970 |
| Other Income | 3 | -8 | -27 | 107 | 93 |
| Pre-tax Income | -2,082 | -3,543 | -3,855 | -6,847 | -2,877 |
| Net Income Continuous | -2,082 | -3,543 | -3,855 | -6,847 | -2,877 |
| Net Income | $-2,082 | $-3,543 | $-3,855 | $-6,847 | $-2,877 |
| EPS Basic Total Ops | -0.86 | -1.50 | -1.63 | -3.82 | -1.26 |
| EPS Basic Continuous Ops | -0.88 | -1.50 | -1.63 | -3.82 | -1.27 |
| EPS Diluted Total Ops | -0.86 | -1.50 | -1.63 | -3.82 | -1.26 |
| EPS Diluted Continuous Ops | -0.88 | -1.50 | -1.63 | -3.82 | -1.27 |
| EBITDA(a) | $-2,085 | $-3,535 | $-3,828 | $-6,954 | $-2,970 |